你即將離開本站

並前往https://www.gynecologiconcology-online.net/article/S0090-8258(21)00538-2/fulltext

The effectiveness of monotherapy with PI3K/AKT/mTOR ...

Monotherapy with PI3K/AKT/mTOR inhibitors resulted in a pooled CBR of 32% and ORR of 3% in ovarian cancer patients.

確定！ 回上一頁

查詢 「PI3K」的人也找了：

  1. pi3k作用
    2.
  2. pi3k抑制劑
    3.
  3. akt磷酸化
    4.
  4. Akt pathway
    5.
  5. PI3K inhibitor
    6.
  6. pi3k inhibitor中文
    7.
  7. pi3k inhibitor藥物
    8.
  8. PI3K pathway
    9.